- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GE Releases AI-Enhanced Women’s Health Ultrasound with Industry-First Tools
Voluson SWIFT is designed to shorten scan time and improve efficiency.
GE Healthcare unveiled its Voluson SWIFT ultrasound system, a tool intended to help women’s health providers augment their diagnostic capabilities and bolster patient outcomes, on Wednesday.
According to a company statement, this product includes industry-first artificial intelligence (AI) algorithms that support auto-recognition, as well as improved augmented design, high image quality, and efficiency features. It is currently 510(k) pending at the U.S. Food & Drug Administration.
Ob/Gyns face some of the highest rates of burnout, a Medscape survey released earlier this year revealed, and the pandemic environment has added pressures. Consequently, company officials said, Voluson SWIFT – which is based on input from 200 women’s health providers – is intended to make daily workflow more manageable.
Courtesy: GE Healthcare
“Voluson SWIFT has redefined one of the most essential tools obstetrics and gynecology clinicians rely on, delivering a contemporary design, intuitive user interface, and intelligent workflow supported by AI,” said Roland Rott, general manager of women’s health ultrasound at GE Healthcare.
Courtesy: GE Healthcare
Based on company details, Voluson SWIFT includes an embedded AI platform that features SonoLyst, the first fully integrated AI tool that recognizes 20 views. These views are recommended by the International Society of Ultrasound in Obstetrics and Gynecology mid-trimester practice guidelines for fetal imaging, and they optimize scan workflow by 73 percent over 2D workflow.
Courtesy: GE Healthcare
In addition, Voluson SWIFT also includes:
- Scan assistant tool that can reduce patient scan times by 45 percent through simplified workflow and personal protocol customization.
- SonoBiometry measurements are 38-percent faster than previous platforms, with three added measurements have increased system automation by 60 percent.
- SonoCNS – part of GE’s Edison intelligence platform, reduces keystrokes for capturing fetal central nervous system planes and measurements by 78 percent.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
AI Adjudication Bolsters Chest CT Assessment of Lung Adenocarcinoma
April 11th 2024The inclusion of simulated adjudication for resolving discordant nodule classifications in a deep learning model for assessing lung adenocarcinoma on chest CT resulted in a 12 percent increase in sensitivity rate.
